CD8<sup>+</sup> T cell responses recognizing immunodominant <i>Chlamydia</i> antigens fail to protect against infection. [PDF]
Guleed S +12 more
europepmc +1 more source
Advances in vaccine adjuvant development and future perspectives. [PDF]
Sinani G, Şenel S.
europepmc +1 more source
Chikungunya in 2025: Comprehensive Insights into Virology, Diagnostics, Vaccines, and Antiviral Therapies. [PDF]
Zheng Z +8 more
europepmc +1 more source
Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses. [PDF]
Rungelrath V +10 more
europepmc +1 more source
Melioidosis vaccines: recent advances and future directions. [PDF]
Sengyee S +4 more
europepmc +1 more source
Neutralizing Antibody Responses to Chlamydia trachomatis in Women and Associations With Chlamydia Outcomes. [PDF]
Yu H +5 more
europepmc +1 more source
Influenza Vaccines: Current Status, Adjuvant Strategies, and Efficacy. [PDF]
Mokalla VR +4 more
europepmc +1 more source
A broader evaluation of vaccine-induced T cell immunity against tuberculosis. [PDF]
Ogongo P.
europepmc +1 more source
Tracking Canada's 2015 vaccine research and development priorities: Where are we a decade later? [PDF]
Moqueet N +8 more
europepmc +1 more source
Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal. [PDF]
Hoseinpour R +11 more
europepmc +1 more source

